Date: 2015-11-12 02:47:43Anatomy Medicine Autoimmune diseases Clinical medicine Mucinoses Drug discovery Systemic scleroderma Orphan drug Scleroderma Mechanistic target of rapamycin | | PRESS RELEASE Genkyotex’s GKT137831 Granted Orphan Drug Designation in the US and EU for the Treatment of Systemic Sclerosis Geneva, Switzerland, and Archamps, France, 11th November, 2015 – Genkyotex, the leading deAdd to Reading ListSource URL: www.biomedvc.comDownload Document from Source Website File Size: 118,03 KBShare Document on Facebook
|